M&T Bank Corp Acquires 343 Shares of National Research Co. (NASDAQ:NRC)

M&T Bank Corp raised its holdings in National Research Co. (NASDAQ:NRCGet Rating) by 3.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 9,223 shares of the company’s stock after buying an additional 343 shares during the period. M&T Bank Corp’s holdings in National Research were worth $354,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of NRC. Hardy Reed LLC bought a new position in National Research in the 1st quarter valued at $37,000. Lazard Asset Management LLC purchased a new stake in shares of National Research in the 1st quarter worth $49,000. Amalgamated Bank purchased a new stake in shares of National Research in the 1st quarter worth $90,000. Strs Ohio lifted its holdings in shares of National Research by 6.3% in the 2nd quarter. Strs Ohio now owns 6,800 shares of the company’s stock worth $260,000 after buying an additional 400 shares during the period. Finally, Envestnet Asset Management Inc. lifted its holdings in shares of National Research by 7.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 8,161 shares of the company’s stock worth $324,000 after buying an additional 599 shares during the period. Institutional investors own 67.51% of the company’s stock.

National Research Price Performance

Shares of NRC stock opened at $36.75 on Tuesday. National Research Co. has a twelve month low of $30.93 and a twelve month high of $47.93. The stock has a market capitalization of $907.39 million, a price-to-earnings ratio of 26.63 and a beta of 0.50. The stock has a fifty day simple moving average of $39.08 and a two-hundred day simple moving average of $36.94. The company has a current ratio of 1.20, a quick ratio of 1.31 and a debt-to-equity ratio of 0.28.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 14th. Shareholders of record on Friday, September 30th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 2.61%. The ex-dividend date of this dividend was Thursday, September 29th. National Research’s dividend payout ratio is 69.57%.

Insiders Place Their Bets

In other National Research news, major shareholder Amandla Mk Trust sold 100,000 shares of the company’s stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $38.59, for a total value of $3,859,000.00. Following the completion of the sale, the insider now directly owns 4,661,639 shares in the company, valued at approximately $179,892,649.01. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders sold 246,555 shares of company stock worth $9,814,070. 2.00% of the stock is currently owned by company insiders.

National Research Profile

(Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

See Also

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCGet Rating).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.